Focus: Medium Biosciences is an AI-focused biotech company specializing in computationally designed protein therapeutics. The company operates as a pre-revenue or early-stage biotech with minimal public disclosure on scale.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Best suited for early-career scientists or specialists willing to accept pre-revenue biotech risk in exchange for deep technical ownership in AI protein design.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Medium Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Medium Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo